[go: up one dir, main page]

AR048830A1 - Preparado polifasico para la contracepcion a base de un estrogeno natural y un gestageno sintetico - Google Patents

Preparado polifasico para la contracepcion a base de un estrogeno natural y un gestageno sintetico

Info

Publication number
AR048830A1
AR048830A1 ARP050101553A ARP050101553A AR048830A1 AR 048830 A1 AR048830 A1 AR 048830A1 AR P050101553 A ARP050101553 A AR P050101553A AR P050101553 A ARP050101553 A AR P050101553A AR 048830 A1 AR048830 A1 AR 048830A1
Authority
AR
Argentina
Prior art keywords
natural
strogen
synthetic gestagen
contraception based
polyphasic
Prior art date
Application number
ARP050101553A
Other languages
English (en)
Inventor
Jan Endrikat
Bernd Dusterberg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR048830(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR048830A1 publication Critical patent/AR048830A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Preparado para la contracepcion a base de un estrogeno natural en combinacion con un gestágeno sintético para mayor seguridad contraceptiva durante todo el ciclo, que mejora el comportamiento cíclico de la hemorragia y minimiza o elimina los efectos secundario tales como tension en los pechos, dolores de cabeza, estados de ánimo depresivos y modificaciones de la libido, etc, en comparacion con los contraceptivos anovulatorios tradicionales del mismo tipo.
ARP050101553A 2004-04-20 2005-04-20 Preparado polifasico para la contracepcion a base de un estrogeno natural y un gestageno sintetico AR048830A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019743A DE102004019743B4 (de) 2004-04-20 2004-04-20 Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens

Publications (1)

Publication Number Publication Date
AR048830A1 true AR048830A1 (es) 2006-05-31

Family

ID=34979546

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050101553A AR048830A1 (es) 2004-04-20 2005-04-20 Preparado polifasico para la contracepcion a base de un estrogeno natural y un gestageno sintetico
ARP110104615A AR084229A2 (es) 2004-04-20 2011-12-12 Preparado polifasico para la contracepcion a base de un estrogeno natural

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP110104615A AR084229A2 (es) 2004-04-20 2011-12-12 Preparado polifasico para la contracepcion a base de un estrogeno natural

Country Status (37)

Country Link
US (3) US8071577B2 (es)
EP (1) EP1740163B2 (es)
JP (1) JP4908399B2 (es)
KR (1) KR20060134168A (es)
CN (1) CN1946383B (es)
AR (2) AR048830A1 (es)
AT (1) ATE473734T1 (es)
AU (1) AU2005235418C1 (es)
BR (1) BRPI0510005A (es)
CA (1) CA2561839C (es)
CR (1) CR8695A (es)
CY (1) CY1111292T1 (es)
DE (2) DE102004019743B4 (es)
DK (1) DK1740163T4 (es)
EA (1) EA010313B1 (es)
EC (1) ECSP067000A (es)
ES (1) ES2348038T5 (es)
GT (1) GT200500093A (es)
HR (1) HRP20100513T4 (es)
IL (2) IL178510A (es)
ME (1) ME01183B (es)
MX (1) MXPA06012213A (es)
MY (1) MY143669A (es)
NO (1) NO344098B1 (es)
NZ (1) NZ550417A (es)
PA (1) PA8630901A1 (es)
PE (1) PE20060308A1 (es)
PL (1) PL1740163T5 (es)
PT (1) PT1740163E (es)
RS (1) RS51434B2 (es)
SI (1) SI1740163T2 (es)
SV (1) SV2006002090A (es)
TW (1) TWI351960B (es)
UA (1) UA83915C2 (es)
UY (1) UY28863A1 (es)
WO (1) WO2005102247A2 (es)
ZA (1) ZA200609594B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE502005006837D1 (de) * 2005-10-13 2009-04-23 Bayer Schering Pharma Ag Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption
DK1937274T3 (da) * 2005-10-13 2012-06-18 Bayer Pharma AG Anvendelse af estradiolvalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blødning i enhed med en oral kontraception
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1993531B1 (en) * 2006-03-02 2015-10-14 Warner Chilcott Company, LLC Extended cycle multiphasic oral contraceptive method
DE102006010329A1 (de) * 2006-03-06 2007-09-13 Höltge, Michael, Dipl.-Med. Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US20090117184A1 (en) * 2007-11-05 2009-05-07 Sabine Fricke Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception
AR086395A1 (es) * 2011-05-11 2013-12-11 Kirax Corp Envase para el tratamiento de patologias

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4168068A (en) 1969-07-22 1971-01-28 Unisearch Limited Improvements in or relating to oral contraceptives
US3639600A (en) 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US4066757A (en) 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2431704A1 (de) 1974-07-02 1976-01-22 Asche Ag Stufenkombinationspraeparate per kontrazeption
DE2645307A1 (de) 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
JPS6019734B2 (ja) 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンe類製剤の製法
US4272270A (en) 1979-04-04 1981-06-09 Petrochem Consultants, Inc. Cryogenic recovery of liquid hydrocarbons from hydrogen-rich
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3341638A1 (de) 1983-11-17 1984-05-03 Hermann Dr.rer.nat. 8000 München Heßlinger Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol
DE3347125A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
AU581486B2 (en) 1985-12-30 1989-02-23 Warner-Lambert Company Graduated estrogen contraceptive
DK174724B1 (da) 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CA2005933A1 (en) 1989-01-09 1990-07-09 Jesse Hipps, Sr. Photohardenable composition containing five member aromatic group with imine moiety
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (es) 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4224534A1 (de) 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4339934C2 (de) 1993-05-07 1995-05-24 Klaus Dr Med Umbreit Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US20050032756A1 (en) 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
PT917466E (pt) 1996-07-26 2004-12-31 Wyeth Corp Contraceptivo oral
PT921804E (pt) 1996-07-26 2004-01-30 Wyeth Corp Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio
ES2223081T3 (es) 1996-07-26 2005-02-16 Wyeth Metodo anticonceptivo oral monofasico y kit que comprende una combinacion de progestina y estrogeno.
US6987101B1 (en) 1996-12-20 2006-01-17 Schering Aktiengesellschaft Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
DE19654609A1 (de) 1996-12-20 1998-06-25 Schering Ag Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6312772B1 (en) * 1997-10-20 2001-11-06 Hoechst Celanese Corporation Multilayer laminate formed from a substantially stretched non-molten wholly aromatic liquid crystalline polymer and non-polyester thermoplastic polymer
DE19908762A1 (de) 1999-02-18 2000-08-31 Jenapharm Gmbh Verwendung von Dienogest in hoher Dosierung
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6699820B2 (en) 2001-03-02 2004-03-02 Hartmut Ulrich Bielefeldt Method for making a superconductor with enhanced current carrying capability
IL161105A0 (en) 2001-09-29 2004-08-31 Solvay Pharm Gmbh Estrogen/gestagen combination preparation and application thereof
EP1462106A1 (en) 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
PT1635843E (pt) 2003-06-25 2009-04-07 Bayer Schering Pharma Ag Terapia de substituição hormonal e de depressão compreendendo dienogest
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
WO2006042021A2 (en) 2004-10-07 2006-04-20 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
TW200726473A (en) 2005-06-28 2007-07-16 Wyeth Corp Compositions and methods for treatment of cycle-related symptoms
DE502005006837D1 (de) 2005-10-13 2009-04-23 Bayer Schering Pharma Ag Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Also Published As

Publication number Publication date
US20070259840A1 (en) 2007-11-08
WO2005102247A2 (de) 2005-11-03
NO344098B1 (no) 2019-09-02
PL1740163T3 (pl) 2010-12-31
TW200534860A (en) 2005-11-01
DK1740163T3 (da) 2010-10-18
DE102004019743B4 (de) 2008-11-27
NZ550417A (en) 2010-01-29
CA2561839C (en) 2009-09-29
WO2005102247A3 (de) 2006-01-12
HK1099701A1 (zh) 2007-08-24
ECSP067000A (es) 2006-12-29
MXPA06012213A (es) 2007-01-17
CY1111292T1 (el) 2015-08-05
US8071577B2 (en) 2011-12-06
PT1740163E (pt) 2010-09-28
US20100173877A1 (en) 2010-07-08
IL178510A0 (en) 2007-02-11
SI1740163T1 (sl) 2010-11-30
NO20065292L (no) 2007-01-17
HRP20100513T4 (hr) 2020-10-02
PL1740163T5 (pl) 2020-10-05
PE20060308A1 (es) 2006-05-25
AR084229A2 (es) 2013-05-02
CR8695A (es) 2008-07-29
ES2348038T5 (es) 2020-09-14
CA2561839A1 (en) 2005-11-03
IL178510A (en) 2015-08-31
CN1946383A (zh) 2007-04-11
RS51434B2 (sr) 2020-11-30
GT200500093A (es) 2006-04-17
DE102004019743A1 (de) 2005-11-24
KR20060134168A (ko) 2006-12-27
ZA200609594B (en) 2008-04-30
RS51434B (sr) 2011-04-30
AU2005235418A1 (en) 2005-11-03
MY143669A (en) 2011-06-30
UY28863A1 (es) 2005-11-30
EA200601844A1 (ru) 2007-04-27
JP2007533681A (ja) 2007-11-22
ES2348038T3 (es) 2010-11-29
EA010313B1 (ru) 2008-08-29
DK1740163T4 (da) 2020-04-06
SV2006002090A (es) 2006-02-15
DE502005009904D1 (de) 2010-08-26
IL239861A0 (en) 2015-08-31
AU2005235418B2 (en) 2009-08-06
EP1740163B2 (de) 2020-01-15
HRP20100513T1 (hr) 2010-11-30
AU2005235418C1 (en) 2015-05-21
TWI351960B (en) 2011-11-11
JP4908399B2 (ja) 2012-04-04
SI1740163T2 (sl) 2020-04-30
EP1740163B1 (de) 2010-07-14
ATE473734T1 (de) 2010-07-15
UA83915C2 (ru) 2008-08-26
CN1946383B (zh) 2010-06-09
US20110124612A1 (en) 2011-05-26
ME01183B (me) 2013-03-20
EP1740163A2 (de) 2007-01-10
BRPI0510005A (pt) 2007-09-18
PA8630901A1 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
AR048830A1 (es) Preparado polifasico para la contracepcion a base de un estrogeno natural y un gestageno sintetico
PE20150305A1 (es) Unidad de ajuste para banda de soporte de casco protector, particularmente para trabajadores forestales
BR112015015031A2 (pt) processo de glicoconjugação
CO6480930A2 (es) Composiciones y procedimientos para preparar composiciones inmunogénicas de conjugado de polisacárido capsular de serotipo 5 y 8 de staphylococcus aureus.
MX339624B (es) Composiciones mejoradas de celulas y metodos para preparar las mismas.
CR10528A (es) Proceso para producir poxvirus y composiciones de poxvirus
AR102701A2 (es) Artículo de calzado
BR112014013840A2 (pt) melhoramentos em e relacionados a almofadas
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
BRPI0510592A (pt) veìculo compreendendo uma turbina eólica acoplada a um gerador elétrico
BR112015012453A8 (pt) métodos e usos para sincronizar o tempo de ovulação e de inseminação em uma leitoa
UY29248A1 (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
AR034451A1 (es) Microcapsulas para la proteccion frente al mal aliento.
CU20060197A7 (es) Preparado polifásico para la contracepción a base de un estrógeno natural
MX2024006489A (es) Producto cosmetico en barra, empaquetado.
CN203090469U (zh) 一种发光气球
CN203028202U (zh) 包边尾夹
UY30368A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion
CR9115A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
CR10428A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparacion, composiciones que las contienen y utilizacion
del Principado PRESENTACIÓN SUPLEMENTO Nº2, PSICOTHEMA
AR049945A1 (es) Auricular preparado para proteccion visual
BRMU8601580U (pt) disposição construtiva em presilha para conformação de bonecos de brinquedo
BRMU8600371U (pt) gorro
GT200500168A (es) Composiciones diels-alder en látexes de elastómeros insaturados

Legal Events

Date Code Title Description
FC Refusal